| http://purl.uniprot.org/citations/34982022 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/34982022 | http://www.w3.org/2000/01/rdf-schema#comment | "Circular RNAs (circRNAs) have shown pivotal regulatory roles in tumorigenesis and progression. Our purpose was to analyze the role of circRNA La ribonucleoprotein 1B (circ-LARP1B; hsa_circ_0070934) in cutaneous squamous cell carcinoma (CSCC) progression and its associated mechanism. Cell viability, colony formation ability, migration, and invasion were analyzed by 3-(4, 5-dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide (MTT) assay, colony formation assay, wound healing assay, and transwell invasion assay. Flow cytometry was performed to analyze cell apoptosis and cell cycle progression. Cell glycolytic metabolism was analyzed using Glucose Uptake Colorimetric Assay kit, Lactate Assay Kit II, and ATP colorimetric Assay kit. Dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay were performed to verify the interaction between microRNA-515-5p (miR-515-5p) and circ-LARP1B or TPX2 microtubule nucleation factor (TPX2). Circ-LARP1B expression was up-regulated in CSCC tissues and cell lines. Circ-LARP1B knockdown suppressed cell viability, colony formation ability, migration, invasion, cell cycle progression, and glycolysis and triggered cell apoptosis in CSCC cells. miR-515-5p was a direct target of circ-LARP1B in CSCC cells, and circ-LARP1B silencing-mediated anti-tumor effects were largely counteracted by miR-515-5p knockdown. miR-515-5p directly interacted with the 3' untranslated region (3'UTR) of TPX2. TPX2 overexpression largely overturned miR-515-5p-mediated anti-tumor effects in CSCC cells. Circ-LARP1B could up-regulate TPX2 expression by sponging miR-515-5p in CSCC cells. Circ-LARP1B knockdown suppressed tumor growth in vivo. In conclusion, circ-LARP1B contributed to CSCC progression by targeting miR-515-5p/TPX2 axis. The circ-LARP1B/miR-515-5p/TPX2 axis might provide novel therapeutic targets for CSCC patients."xsd:string |
| http://purl.uniprot.org/citations/34982022 | http://purl.org/dc/terms/identifier | "doi:10.1080/21655979.2021.2019172"xsd:string |
| http://purl.uniprot.org/citations/34982022 | http://purl.uniprot.org/core/author | "Hou S."xsd:string |
| http://purl.uniprot.org/citations/34982022 | http://purl.uniprot.org/core/author | "Li J."xsd:string |
| http://purl.uniprot.org/citations/34982022 | http://purl.uniprot.org/core/author | "Tian T."xsd:string |
| http://purl.uniprot.org/citations/34982022 | http://purl.uniprot.org/core/author | "Wang L."xsd:string |
| http://purl.uniprot.org/citations/34982022 | http://purl.uniprot.org/core/author | "Hu R."xsd:string |
| http://purl.uniprot.org/citations/34982022 | http://purl.uniprot.org/core/author | "Yu N."xsd:string |
| http://purl.uniprot.org/citations/34982022 | http://purl.uniprot.org/core/date | "2022"xsd:gYear |
| http://purl.uniprot.org/citations/34982022 | http://purl.uniprot.org/core/name | "Bioengineered"xsd:string |
| http://purl.uniprot.org/citations/34982022 | http://purl.uniprot.org/core/pages | "1209-1223"xsd:string |
| http://purl.uniprot.org/citations/34982022 | http://purl.uniprot.org/core/title | "Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis."xsd:string |
| http://purl.uniprot.org/citations/34982022 | http://purl.uniprot.org/core/volume | "13"xsd:string |
| http://purl.uniprot.org/citations/34982022 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/34982022 |
| http://purl.uniprot.org/citations/34982022 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/34982022 |
| http://purl.uniprot.org/uniprot/#_B3KM90-mappedCitation-34982022 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34982022 |
| http://purl.uniprot.org/uniprot/#_Q643R0-mappedCitation-34982022 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34982022 |
| http://purl.uniprot.org/uniprot/#_Q9ULW0-mappedCitation-34982022 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34982022 |
| http://purl.uniprot.org/uniprot/#_Q96FC3-mappedCitation-34982022 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34982022 |
| http://purl.uniprot.org/uniprot/B3KM90 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/34982022 |
| http://purl.uniprot.org/uniprot/Q9ULW0 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/34982022 |
| http://purl.uniprot.org/uniprot/Q643R0 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/34982022 |
| http://purl.uniprot.org/uniprot/Q96FC3 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/34982022 |